SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615219-21-000026
Filing Date
2021-03-18
Accepted
2021-03-18 17:16:18
Documents
63
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K flks-20201231.htm   iXBRL 10-K 1311207
2 EX-4.11 slrx12312019descriptionofr.htm EX-4.11 24183
3 EX-23.1 slrx2020eydraftconsent10-k.htm EX-23.1 4739
4 EX-31.1 slrx20191231ex-311.htm EX-31.1 10797
5 EX-31.2 slrx12312019-312expfocerti.htm EX-31.2 10826
6 EX-32.1 slrx12312019-321ex906peoce.htm EX-32.1 5638
7 EX-32.2 slrx12312019-322ex906pfoce.htm EX-32.2 5454
  Complete submission text file 0001615219-21-000026.txt   5475619

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20201231.xsd EX-101.SCH 33732
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20201231_cal.xml EX-101.CAL 71690
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20201231_def.xml EX-101.DEF 206470
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20201231_lab.xml EX-101.LAB 517859
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20201231_pre.xml EX-101.PRE 331240
13 EXTRACTED XBRL INSTANCE DOCUMENT flks-20201231_htm.xml XML 662223
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36812 | Film No.: 21755402
SIC: 2834 Pharmaceutical Preparations